Clinical Trials, Corneal Crosslinking, CXL, PRK, TCAT, Keratoconus, Post Lasik Ectasia, Myopia

Are you a candidate for LASIK eye surgery? Take our test and hear from our consultants. If you have been seeking LASIK in Houston, please contact us and we can help you establish a path to better vision.

Our Houston LASIK eye surgery center goes way beyond what other centers do to help our patients overcome affordability issues with LASIK surgery.

One of the best ways to evaluate a LASIK practice is to listen to what other patients say about the surgeon, the facility and the procedure.

Our physicians, technicians and staff guarantee to our patients our commitment to the highest standards of medical care, compassion and customer service.

At Slade & Baker Vision Correction, we strive to offer our patients educational resources about eye conditions and treatment options.

Clinical Trials

Visit Our Blog

Slade & Baker Vision Center is constantly being sought out by device and pharmaceutical companies to conduct clinical trials in order to help them gain FDA approval. Often, patients who are eligible for these clinical trials receive significant discounts for their participation. Current clinical trials being conducted at Slade & Baker Vision Center are listed below. Please call our office to learn more.

PRK Study

A new PRK study is now available at Slade and Baker Vision. The study is looking for nearsighted patients that desire to have their distance vision corrected with PRK. After PRK a new type of bandage soft contact lens is placed on the eye. The new bandage lens is designed to provide functional vision immediately during the healing phase by keeping its shape and promote faster visual recovery as well. The international results have shown patients return to their normal activities much sooner than with traditional PRK (more on par with LASIK patients). A patient's predicted corneal curvature post surgery must match the curves the company currently makes in order for the patient to be a candidate for this study. Prospective patients should come in for a complimentary screening. If you are determined to be a candidate for this study, the bandage lens company will pay for your PRK surgery. Please click on this link for more information regarding PRK and this study.

Corneal Crosslinking (CXL)

Slade and Baker Vision now offers corneal crosslinking (CXL), an investigational treatment option for certain corneal conditions. CXL is designed to treat Keratoconus, a disease that results in increasing nearsightedness and astigmatism. CXL may also be used to treat certain complications after LASIK surgery, primarily Post Lasik Ectasia patients that experience corneal thinning after Refractive Surgery. CXL treatment consists of a combination of applying Riboflavin drops, a B vitamin, to the front surface of the eye along with the use of an ultraviolet light. CXL has been approved in other parts of the world, but is under an FDA Study here in the US. CXL is performed using an investigational device that has not been fully approved in the US. Dr. Slade and Dr. Baker are investigators for this FDA Study. While any procedure, even wearing contact lenses, carries some risks, CXL is associated with low risks. In the other parts of the world, where CXL is approved, results are excellent.

Slade and Baker are now offering CXL for their patients and referral patients under the FDA Study. Slade & Baker Vision Center was the first site in Texas that was approved by the FDA to perform Crosslinking. We are still currently performing Crosslinking as an FDA trial. Please visit the National Keratoconus Foundation's website to see all the approved CXL sites in the United States. Enrollment in the trial is limited. The best first step is to come in to the clinic for a screening evaluation to find out if you are eligible. There is no charge for this screening visit. We look forward to seeing you!

T-CAT Study

This LASIK study is for patients who are nearsighted, farsighted or have astigmatism. In this study we use a new, custom LASIK treatment pattern. The treatment pattern is approved in Europe and we are assisting in gaining its approval in the US. Early results are impressive. A significant reduction in the cost for LASIK is provided to patients for their participation. Qualifying patients must be 18 years of age or older.

Presbylens

Presbylens is a unique treatment for presbyopia. Presbyopia is the loss of near vision with age and it typically happens to everyone over 40 years of age. The Presbylens is a microscopic clear lens that is implanted in the cornea. A small LASIK-like flap is made with a laser; the Presbylens is laid on the cornea under the flap; and the corneal flap is returned to its original position where it bonds without stitches. No corneal tissue is removed and the lens is removable if needed. This technique is approved in Europe and we are assisting in gaining its approval in the US. For patients who qualify for the Presbylens study, the surgery will be performed at no charge.